| Name | Title | Contact Details |
|---|
Another Broken Egg Cafe is a popular brunch chain founded in 1996 in Mandeville, Louisiana. Originally named The Broken Egg Cafe, it was rebranded to highlight its unique brunch offerings. The cafe is known for its New Orleans heritage and serves a variety of breakfast, brunch, and lunch dishes, including omelets, pancakes, and sandwiches, all made with quality ingredients. The beverage menu features specialty coffee drinks, mimosas, and cocktails that complement the food. The chain operates over 90 locations across the United States, primarily in the Southeast, and is led by CEO Paul Macaluso. Under his leadership, the company is expanding through franchising, aiming to reach 100 locations. Another Broken Egg Cafe focuses on creating a welcoming atmosphere in its restaurants, often incorporating local elements to enhance the dining experience. The company also utilizes advanced technology to improve operations and customer service.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Wellabe is a U.S.-based insurance provider with a rich history dating back to 1929. Originally founded as American Republic Insurance Company, it rebranded in 2023 following a merger of six subsidiaries under American Enterprise Group, Inc. The name "Wellabe" reflects its commitment to reliability and long-term customer support. The company specializes in health and financial protection solutions, offering a range of insurance products. These include Medicare Supplement insurance, Hospital Indemnity coverage, Preneed Insurance for funeral expenses, Short-term Care Insurance, and Final Expense Life Insurance. Wellabe also partners with organizations like Start Hearing®, VSP® Individual Vision Plans, and CancerEDGE™ to enhance its supplemental health services. The company primarily serves older adults and retirees, focusing on their needs for aging, chronic conditions, and end-of-life planning. Wellabe is dedicated to customer-centric values, emphasizing integrity and community engagement.
Sisu is an industry thought leader in the fields of robotics and automation. We take on complex engineering problems that often involve adopting or inventing new technologies. We are disrupting the cinema, industrial knife sharpening, welding, and other industries. With robots that are easy to program, its no wonder that we are one of the fastest-growing cinema robotics companies in the world! We provide a fast-paced and exciting work environment, built on values of hard work and family, attracting top talent from across the country. Sisu is located in beautiful Austin Texas and serves customers in the United States and around the world. Sisu is a Kuka Robotics System Partner and an alliance partner with National Instruments.